A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1986
11/11/1986	US4622222 Storage stability
11/06/1986	WO1986006494A2 Means for in vitro diagnostic of malignant cells originating from the digestive tube
11/06/1986	WO1986006490A1 Method for augmenting immune response
11/06/1986	WO1986006414A1 Synthetic antigens for the detection of aids-related disease
11/05/1986	EP0200653A1 Hybrid cells producing a hepatitis B virus antigen obtained from hepatocytes and established monkey cells, process for the obtention of these hybrid cells and use thereof in the production of this antigen
11/05/1986	EP0200554A2 Hybridomas producing monoclonal antibodies specific for mouse interleukin-2
11/05/1986	EP0200539A2 Method of preparing coating compositions containing antisera and elements containing same
11/05/1986	EP0200464A2 A tumor associated antigen
11/05/1986	EP0200412A2 Method of conferring immunotolerance to a specific antigen
11/05/1986	EP0200231A2 Methods for preparing rabbit monoclonal antibodies, the cell lines used therein and the antibodies produced thereby
11/05/1986	EP0199963A1 Ethosuximide assay tracers, immunogens and antibodies
11/05/1986	EP0199756A1 Monoclonal antibodies and their use
11/05/1986	EP0199754A1 Monoclonal antibodies and their use
11/05/1986	EP0093436B1 Process for preparing permanent animal and human cell lines, and their use
11/05/1986	CN86102090A Procedure for obtaining, dna, rna, peptides, polypeptides, or proteins by recombinant dna techemiques
11/04/1986	US4621054 Biologically active substance, process for preparing the substance and immunoactive composition
11/04/1986	US4620978 Hepatitis A virus purified and triply cloned
11/04/1986	US4620977 Treatment methods, particularly for psychoactive drug dependence
11/04/1986	CA1213539A2 Bacterial polypeptide expression employing tryptophan promoter-operator
11/04/1986	CA1213538A1 Dna fragments coding for an immunogen peptide liable of inducing in vivo the synthesis of anti-poliovirus antibodies
11/04/1986	CA1213536A1 Monoclonal antibody, method of producing the same and use thereof
10/1986
10/29/1986	EP0199698A2 Process for the extraction and purification of proteins from culture media producing them
10/29/1986	EP0199586A2 Tumour-associated antigen
10/29/1986	EP0199480A2 Hepatitis A virus vaccines
10/29/1986	EP0199479A2 Ozone decontamination of blood and blood products
10/29/1986	EP0199301A1 Recombinant acquired immune deficiency syndrome (AIDS) viral envelope protein and method of testing for AIDS
10/29/1986	EP0199223A2 Purification of immunoglobulin G
10/29/1986	EP0199141A2 Monoclonal antibodies to human gastrointestinal cancer
10/29/1986	EP0199091A1 Process for the production of a herpes simplex virus type 2 specific antigen, suitable agents therefor and the use of this antigen
10/29/1986	EP0199042A1 Procainamide assay, tracers, immunogens and antibodies
10/29/1986	EP0198882A1 Stabilization of biological substances
10/29/1986	EP0198866A1 Monoclonal antibodies and their use
10/29/1986	EP0198828A1 Infectious bursal disease virus vaccine
10/28/1986	US4619828 Polysaccharide exotoxoid conjugate vaccines
10/28/1986	US4619827 Method for administering equine vaccines and compositions therefor
10/28/1986	CA1213234A1 Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine
10/28/1986	CA1213229A1 Antibodies having dual specificities, their preparation and uses therefor
10/28/1986	CA1213215A1 Stabilization of influenza virus vaccine
10/28/1986	CA1213213A1 Protein (pp.sub.1.sub.3), a process for enriching and isolating it and its use
10/28/1986	CA1213212A1 Protein (pp in17 xx), a process for concentrating and isolating it and its use
10/23/1986	WO1986006099A1 EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV
10/23/1986	WO1986006079A1 Purified protein having angiogenic activity and methods of preparation
10/23/1986	WO1986006076A1 Recombinant inhibin
10/23/1986	WO1986006075A1 Highly repetitive antigens of plasmodium falciparum
10/23/1986	WO1986005977A1 Steroidal liposomes
10/22/1986	EP0198474A1 Hepatitis B surface antigen formed by recombinant DNA techniques, vaccines, diagnostics, cell lines and methods of forming same
10/22/1986	EP0198328A2 Vaccinia DNA
10/22/1986	EP0198299A2 A process for preparing hepatitis B surface antigen containing particles in novel forms which are highly immunogenic
10/22/1986	EP0198259A1 Method for the immunological determination of heparan sulphate proteoglycan, and method for the extraction or purification of heparan sulphate proteoglycan suited therefor from or of tissues containing basal membranes
10/22/1986	EP0198039A1 $i(AOTUS) INTERSPECIES HYBRIDOMAS AND MONOCLONAL RECEPTORS PRODUCED THEREBY
10/22/1986	EP0197974A1 Acino-foetal differentiation proteins associated to the pancreas cancer, antiserum and monoclonal antibodies to said proteins, preparation methods
10/21/1986	US4618588 Reagent and merchandising kit for use in the diagnosis of syphilis and preparation thereof
10/21/1986	US4618578 Expression of glycoprotein D of herpes simplex virus
10/21/1986	US4618493 Temperature sensitive strains of bovine viral diarrhoea virus, preparation thereof and vaccines containing them
10/21/1986	US4618492 Crosslinking agents that permit controlled release of amino-group-containing substances under mildly acidic conditions
10/21/1986	US4618486 Monoclonal antibody formulation for diagnostic use
10/21/1986	CA1212900A1 Urea-linked immunogens, antibodies, and preparative method
10/15/1986	EP0197772A2 Peptides useful in vaccination against enteroviruses
10/15/1986	EP0197489A2 Hypoxanthin-guanin-phosphoribosyltransferase-negative mutants of a histiocyte permanent human cell line
10/15/1986	EP0197435A2 Choriocarcinoma monoclonal antibodies and antibody panels
10/15/1986	EP0197062A1 Anti-leishmania monoclonal antibodies, hybridomas secreting said antibodies, antigens of leishmania recognized by said antibodies, method for obtaining them and applications of said monoclonal antibodies and said antigens.
10/15/1986	EP0050648B1 Means and method to provide lasing
10/15/1986	CN86101798A Process for the extraction and purification of proteins from culture media producing them
10/15/1986	CN85102340A Process for the preparation of acyltripeptide immunosttimulants
10/14/1986	US4617379 High titer cytomegalovirus immune serum globulin
10/14/1986	CA1212642A1 Process for producing proteins correlated with the diphtheric toxin
10/14/1986	CA1212640A1 Process for producing the a and b subunits of cholera toxin, preparations containing so-obtained subunit or subunits, dna sequences and recombinant dna molecules related thereto
10/14/1986	CA1212625A1 Methods for preparation of hb.sub.sag free gamma globulins and products
10/09/1986	WO1986005816A1 Type-specific papillomavirus dna sequences and peptides
10/09/1986	WO1986005806A1 Infectious bronchitis virus spike protein
10/09/1986	WO1986005803A1 Method for obtaining dna, rna, peptides, polypeptides or proteins by means of a dna recombinant technique
10/09/1986	WO1986005790A1 Immunogenic antigen-carrier protein conjugate for use in a vaccine against malaria
10/09/1986	WO1986005692A2 Treatment of adult respiratory distress syndrome
10/09/1986	WO1986005691A1 Non-adjuvenated vaccine
10/08/1986	EP0196762A1 Recombinant ricin fragments, vectors and transformed hosts expressing the same, the modification of DNA sequences, and isolation of mRNA
10/08/1986	EP0196761A2 Method of virus-inactivating heat treatment of gamma-globulin
10/08/1986	EP0196515A1 Photodynamic inactivation of virus in therapeutic protein compositions
10/08/1986	EP0196316A1 Hepatitis a virus purified and triply cloned
10/07/1986	US4616079 Dialysis, then high pressure liquid chromatography
10/07/1986	US4615985 Hydrolysis, actlation and reacting with diimide to bind protein to nylon
10/07/1986	US4615973 Genetically engineered organisms expressing surface proteins of T. cruzi
10/07/1986	US4615884 Method and vaccine for treatment of demyelinating diseases
10/07/1986	CA1212320A1 Ozone inactivated organisms as vaccines
10/01/1986	EP0196290A2 Anaplasma marginale subunit antigen for vaccination and diagnosis
10/01/1986	EP0196226A2 Method for preparing a monoclonal antibody against plasminogen-activating factor
10/01/1986	EP0196215A1 Recombinant surface antigens of swine mycoplasma and vaccines and diagnostics based on them
10/01/1986	EP0196007A2 Desmosine derivatives and reagent for preparing artificial antigens
10/01/1986	CN86100726A Process for the preparation of canine parvovirus vaccines
09/1986
09/30/1986	US4614793 Polypeptides
09/30/1986	US4614722 Method and apparatus for measuring the degree of reaction between antigens and leukocyte cellular antibodies
09/30/1986	US4614650 Cytotoxic composition including at least an immunotoxine and an amine
09/30/1986	CA1212052A1 Purification of monoclonal antibodies
09/25/1986	WO1986005592A1 Antigenically active protein and its use in the diagnosis of gonorrhoea
09/25/1986	WO1986005513A1 Hybrid-gene cassette vector
09/25/1986	WO1986005400A1 Antigens, antibodies and their uses
09/25/1986	WO1986005399A1 Pharmaceutical preparations or blood fluidification
09/25/1986	WO1986005396A1 E87ag antigen of pseudomonas aeruginosa, monoclonal antibody against it, and hybridoma
09/24/1986	EP0195680A2 The synthesis of protein with an identification peptide
09/24/1986	EP0195334A2 Process for the disruption of blossom pollen
09/24/1986	EP0195331A2 Monoclonal antibodies against atrial natriuretic peptides

1 ... 1783 1784 1785 1786 1787 1788 1789 1790 1791 1792 1793 1794 1795 1796 1797 1798 1799 1800 1801 1802 1803 ... 1823